Literature DB >> 10613788

Late-onset central hypoventilation with hypothalamic dysfunction: a distinct clinical syndrome.

E S Katz1, S McGrath, C L Marcus.   

Abstract

Idiopathic central hypoventilation has occasionally been reported in previously well children after infancy. The relationship between this late-onset central hypoventilation syndrome (LO-CHS) and congenital central hypoventilation syndrome (CCHS) has not been established. Both CCHS and LO-CHS have been associated with neural crest tumors, such as ganglioneuroblastoma and ganglioneuroma, and they generally occur in the presence of a histologically normal central nervous system. At least 10 case reports of idiopathic LO-CHS featured evidence of hypothalamic dysfunction (HD), including hyperphagia, hypersomnolence, thermal dysregulation, emotional lability, and endocrinopathies. We report on a case of LO-CHS/HD successfully treated by nasal intermittent positive pressure ventilation (NIPPV). Despite the commonalties with CCHS, we propose that LO-CHS/HD is a distinct clinical syndrome. In addition to the markedly different age at presentation, features of hypothalamic dysfunction are not seen in CCHS. Review of the literature was undertaken to further clarify the full spectrum of the disease. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10613788     DOI: 10.1002/(sici)1099-0496(200001)29:1<62::aid-ppul10>3.0.co;2-m

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  22 in total

1.  Cyclophosphamide for rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome.

Authors:  Ido Paz-Priel; David W Cooke; Allen R Chen
Journal:  J Pediatr       Date:  2010-08-21       Impact factor: 4.406

Review 2.  A Narrative Review of Medical and Genetic Risk Factors among Children Age 5 and Younger with Severe Obesity.

Authors:  Nazrat Mirza; Thao-Ly Phan; June Tester; Angela Fals; Cristina Fernandez; George Datto; Elizabeth Estrada; Ihuoma Eneli
Journal:  Child Obes       Date:  2018-05-23       Impact factor: 2.992

3.  PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome.

Authors:  Delphine Trochet; Louise M O'Brien; David Gozal; Ha Trang; Agneta Nordenskjöld; Béatrice Laudier; Pär-Johan Svensson; Sabine Uhrig; Trevor Cole; Stephan Niemann; Arnold Munnich; Claude Gaultier; Stanislas Lyonnet; Jeanne Amiel
Journal:  Am J Hum Genet       Date:  2005-01-18       Impact factor: 11.025

4.  Central Hypoventilation Syndromes.

Authors:  Christopher Cielo; Carole L Marcus
Journal:  Sleep Med Clin       Date:  2014-03-01

5.  Central hypoventilation with PHOX2B expansion mutation presenting in adulthood.

Authors:  Shaney Barratt; Adrian Kendrick; Fiona Buchanan; Adam Whittle
Journal:  BMJ Case Rep       Date:  2009-02-02

Review 6.  Rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation (ROHHAD): a case with additional features and review of the literature.

Authors:  H B Chew; L H Ngu; W T Keng
Journal:  BMJ Case Rep       Date:  2011-03-01

7.  Central Alveolar Hypoventilation Syndromes.

Authors:  Hiren Muzumdar; Raanan Arens
Journal:  Sleep Med Clin       Date:  2008-12-01

8.  Effect of sleep stage on breathing in children with central hypoventilation.

Authors:  Jingtao Huang; Ian M Colrain; Howard B Panitch; Ignacio E Tapia; Michael S Schwartz; John Samuel; Michelle Pepe; Preetam Bandla; Ruth Bradford; Yael P Mosse; John M Maris; Carole L Marcus
Journal:  J Appl Physiol (1985)       Date:  2008-05-22

9.  Central hypoventilation with PHOX2B expansion mutation presenting in adulthood.

Authors:  S Barratt; A H Kendrick; F Buchanan; A T Whittle
Journal:  Thorax       Date:  2007-10       Impact factor: 9.139

10.  Cortical processing of respiratory occlusion stimuli in children with central hypoventilation syndrome.

Authors:  Jingtao Huang; Carole L Marcus; Preetam Bandla; Michael S Schwartz; Michelle E Pepe; John M Samuel; Howard B Panitch; Ruth M Bradford; Yael P Mosse; John M Maris; Ian M Colrain
Journal:  Am J Respir Crit Care Med       Date:  2008-07-24       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.